Autofluorescence in Surgery for Primary Hyperparathyroidism

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAarhus University Hospital

About this trial

The study aims to test if autofluorescence imaging (AF) is a useful surgical aid during parathyroidectomy (PTX) for primary hyperthyroidism (PHPT).

Eligibility criteria

Qualifiers

Age>18 years and able to give informed consent.

A diagnosis of PHPT.

Planned exploratory PTX with ioPTH measurement.

Disqualifiers

Concordant high-confidence imaging; planned focused/selective PTX

Previous thyroid or parathyroid surgery.

Planned simultaneous thyroid surgery.

MEN, lithium induced hyperparathyroidism.

Trial design

Treatments tested in this trial

  • Surgery with autofluorescence

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators